Jiangsu Hansoh Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for JIANGSU HANSOH PHARM, and what generic and branded alternatives to JIANGSU HANSOH PHARM drugs are available?
JIANGSU HANSOH PHARM has ten approved drugs.
There is one tentative approval on JIANGSU HANSOH PHARM drugs.
Drugs and US Patents for Jiangsu Hansoh Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jiangsu Hansoh Pharm | PEMETREXED DISODIUM | pemetrexed disodium | POWDER;INTRAVENOUS | 208696-001 | May 25, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Jiangsu Hansoh Pharm | OLANZAPINE | olanzapine | TABLET;ORAL | 209399-002 | Sep 24, 2018 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Jiangsu Hansoh Pharm | FULVESTRANT | fulvestrant | SOLUTION;INTRAMUSCULAR | 214682-001 | Feb 10, 2022 | AO | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Jiangsu Hansoh Pharm | BORTEZOMIB | bortezomib | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 215011-001 | Jul 26, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Jiangsu Hansoh Pharm | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 202485-001 | May 7, 2013 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Jiangsu Hansoh Pharm | AZACITIDINE | azacitidine | POWDER;INTRAVENOUS, SUBCUTANEOUS | 215905-001 | Jun 28, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.